Therefore, the up‐regulated serum levels of IL‐37 may be due to a feedback mechanism to counter pro‐inflammatory cytokines that exhibit elevated serum levels in T2DM.3 This evidence concerns the gene IL37 and type 2 diabetes mellitus.